Skip to main content

USC Licenses NextBio's Software Suite for Genomic Research

Premium

NextBio said this week that the University of Southern California has licensed its Enterprise platform to support its genomic research efforts.

NextBio's platform supports research collaborations and translational research projects in addition to providing access to curated genomic data and data and literature search functions, the company said.

Satnam Alag, NextBio's vice president of engineering, said that the license gives USC users access to application programming interfaces and allows them to "import unlimited amounts of their own data, and interpret it in the context of our semantically integrated library to make novel insights."

For example, vertical applications like NextBio's Body Atlas and Pharmaco Atlas let users correlate their results with existing genomic data for multiple tissues, compounds, and diseases, he explained.

University researchers will likely use the platform for projects in clinical and translational health sciences and neuroscience, among other areas, NextBio said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.